AzTrials
AzTrials

Pilonidal DiseaseNCT05439291

Comparing Operative vs Non Operative Treatment for Pilonidal Disease

A study testing Regular Epilation Regimen and Surgical excision in people with Pilonidal Disease, run by Stanford University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation. Read more about this study

Who is it for?
Ages 8 years and older
Conditions the study is for
Pilonidal Disease
What is being tested?
Regular Epilation Regimen and Surgical excision
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteUnited States
Study dates
19 Jul 2022to Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients at Stanford Healthcare with pilonidal disease.
  • Patients over the age of 8yrs.

Who cannot join

  • Inability to read, write or understand English ***or Spanish
  • Intellectual disability precluding the patient from being able to comprehend or respond to the questionnaire

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • Stanford University School of Medicine

    Palo Alto, California, 94304

    Bill Chiu, 650-723-6439, bchiu@stanfordchildrens.org

    Recruiting

Other trials in United States

About this study

The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation.

Read the detailed description

The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation. Patients with pilonidal disease can have significant pain and drainage at the gluteal cleft, and recurrent disease in this teenage and young adult population often leads to social embarrassment, isolation, and time off from work or school. Effective therapy to prevent recurrent disease is urgently needed.

The current standard of care is excision of pilonidal cyst. The research will consist of randomized 1:1 controlled trial comparing regular epilation regimen only vs. regular epilation regimen with surgical excision. The research will consist of patient surveys and clinical notes. Surgical excision is not needed to be part of this research.

All patients will receive surveys and their charts will be reviewed. At the point of treatment decision making, the patients will be randomized to one of the two options.

Being tested
Regular Epilation Regimen, Surgical excision
Keywords
Pilonidal Surgery, Pilonidal Excision, Pilonidal recurrence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Regular Epilation RegimenProcedure or surgery

    Epilation using laser device

  • Surgical excisionProcedure or surgery

    Excision of pilonidal pit with trephine

Study groups in NCT05439291
Study groupRoleWhat they receive
Regular epilation regimen onlyActive comparatorNot described
Receives: Procedure: Regular Epilation Regimen
Regular epilation regimen with surgical excisionActive comparatorNot described
Receives: Procedure: Regular Epilation Regimen; Procedure: Surgical excision

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants with recurrent symptoms of pilonidal disease

    Measured: Up to 1 year

Secondary outcomes (4)
  1. Number of participants requiring antibiotic treatment

    Measured: Up to 1 year

  2. Time taken off from school or work due to pilonidal disease

    Measured: Up to 1 year

  3. Effect on parent's daily activities

    Parents measure the effect of caring for afflicted children on a 0-10 rating scale, higher scores correspond to more difficulties.

    Measured: Baseline to 1 year

  4. Number of participants requiring additional surgical intervention

    Measured: Up to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jun 2022
  2. Study start19 Jul 2022
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
The research will consist of randomized 1:1 controlled trial comparing regular epilation regimen only vs. regular epilation regimen with surgical excision
Masking
None (open label)
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05439291
Sponsor's protocol ID
IRB-65058
Status last verified
Nov 2024
First submitted
9 Jun 2022
Last updated
22 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Regular Epilation Regimen and Surgical excision in people with Pilonidal Disease, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bill Chiu, MD (650-723-6439, bchiu@stanfordchildrens.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants with recurrent symptoms of pilonidal disease (time frame: Up to 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in